Development of a Registry of Patients With Pancreatic Exocrine Insufficiency of Different Etiologies
Overview
- Phase
- Not Applicable
- Intervention
- Pancreatic Enzyme
- Conditions
- Exocrine Pancreatic Insufficiency
- Sponsor
- Hospital Clinico Universitario de Santiago
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- Dose of oral pancreatic enzymes
- Last Updated
- 3 years ago
Overview
Brief Summary
A prospective, cross-sectional, observational study has been designed with the aim of the study is to evaluate the diagnosis and management of patients with pancreatic exocrine insufficiency secondary to different pancreatic diseases and conditions in clinical practice.
A registry has been develop to include patients older than 18 years diagnosed with pancreatic exocrine insufficiency, sho are willing to participate in the study and sign the informed consent.
Registry includes demographics, toxic habits,pharmacological therapies, underlying disease that causes pancreatic exocrine insufficiency.
Investigators
J. Enrique Domínguez-Muñoz
Head of the Department of Gastroenterology
Hospital Clinico Universitario de Santiago
Eligibility Criteria
Inclusion Criteria
- •Patients older than 18 years diagnosed with PEI secondary to pancreatic diseases, pancreatectomy, or gastrectomy.
- •Willingness to participate in the study.
Exclusion Criteria
- •Patients with pancreatic diseases without PEI.
- •Pregnancy
- •Known allergy to oral pancreatic enzymes
- •Any condition avoiding adequate clinical management of PEI.
- •Patients who are not willing to participate in the study.
Arms & Interventions
Case
Adult patients diagnosed with pancreatic exocrine insufficiency of any etiology
Intervention: Pancreatic Enzyme
Outcomes
Primary Outcomes
Dose of oral pancreatic enzymes
Time Frame: Six months
Dose required for symptoms relief and normalization of the nutritional status